Search
Aeon Biopharma Inc
AEONAdd to Watchlist
0.243USD
-0.003-1.22%
Close 09-18 16:00（ET）
6.45MMarket Cap
LossP/E TTM
After-hours 18:30 (ET)0.243USD-0.001-0.41%
After-hours 18:30 (ET)AEON Analyst Recommendation Trends
In the current month, AEON has received 2 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. AEON average Analyst price target in the last month is 1.525.
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
2026-03
2026-02
0
0
0
0
0
0
0
0
2
2
2
2
2
2
2
2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
2
2
2
2
2
2
2
Financial Forecasting
Based on analysts' estimates, AEON EPS is projected to reach -0.068 in FY2026Q3, following reported EPS of -0.023 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2026
FY2026Q1
FY2026Q2
FY2025Q3
FY2025Q4
FY2026Q3
FY2026Q4
Forecast
--
--
-0.12
-0.43
-0.13
-0.07
-0.07
Actual
-0.29
-0.29
-0.02
--
--
--
--
Surprise
--
--
+80.95%
--
--
--
--
FAQs
How have Aeon Biopharma IncAEON's recent earnings per share performed?
The market expectation was USD -0.02, while Aeon Biopharma IncAEON's earnings per share (EPS) for the previous quarter was USD -0.29. EPS for the next quarter is expected at USD -0.07.
What is the analyst rating for Aeon Biopharma Inc?
Based on the ratings of Aeon Biopharma Inc's stock from 2 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.